Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
Subscribe
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      Johnson & Johnson's one-dose vaccine closes in on US approval
      Malaysiakini
      World
      Johnson & Johnson's one-dose vaccine closes in on US approval

      Johnson & Johnson's one-dose vaccine closes in on US approval

      ReutersPublished: Feb 25, 2021 1:12 AM

      Johnson & Johnson's one-dose Covid-19 vaccine appeared safe and effective in trials, the US Food and Drug Administration said Wednesday, paving the way for its approval for emergency use as soon as this week.

      The vaccine was 66 percent effective at preventing moderate to severe Covid-19 in a 44,000-person global trial, the FDA said in documents ahead of a Friday meeting of independent experts who will advise the agency on the emergency authorisation...

      Who are not encouraged to take the Covid-19 vaccine?

      Who are not encouraged to take the Covid-19 vaccine?

      Common side effects of Moderna, Pfizer-BioNTech Covid-19 vaccines

      Common side effects of Moderna, Pfizer-BioNTech Covid-19 vaccines

      Covid vaccine reducing risk of hospitalisations, Scottish study suggests

      Covid vaccine reducing risk of hospitalisations, Scottish study suggests

      AstraZeneca/Oxford vaccine more effective with longer dose gap - study

      AstraZeneca/Oxford vaccine more effective with longer dose gap - study

      US data: First month of shots find no safety issues with Pfizer/BioNTech, Moderna vaccines

      US data: First month of shots find no safety issues with Pfizer/BioNTech, Moderna vaccines

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports5

      Who are not encouraged to take the Covid-19 vaccine?

      23-02-2021

      Common side effects of Moderna, Pfizer-BioNTech Covid-19 vaccines

      23-02-2021

      Covid vaccine reducing risk of hospitalisations, Scottish study suggests

      22-02-2021

      AstraZeneca/Oxford vaccine more effective with longer dose gap - study

      20-02-2021

      US data: First month of shots find no safety issues with Pfizer/BioNTech, Moderna vaccines

      20-02-2021
      View Comments0

      Comment0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      600 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor